| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |